Pertussis containing vaccine

ApprovedVaccine

Pertussis containing vaccine is one of 38 small molecule programs targeting Whooping Cough. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Whooping CoughActive, not recruiting

MeningitisActive, not recruiting

Whooping CoughApproved

Active, not recruiting

MeningitisApproved

Active, not recruiting

Competition

Competitive Landscape

52 competitors in Meningitis

#DrugCompanyPhaseTrials

Cipro

Bayer

Approved

2 2

Doribax

Rifadin

Dalalone

CCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Approved

1 5

Sporanox

SSebela Pharmaceuticals Development LLC

Approved

—6

Cubicin

BBaxter Healthcare Corporation

Approved

—7

Intrathecal Methotrexate

Amgen

Approved

1 8

Intrathecal Cytarabine

Pacira Pharmaceuticals, Inc

Approved

1 9

Decadron

AAspen Global Incorporated

Phase 3

2 10

Zyvox

Pfizer

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Meningitis1 trial

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Completed·PPublic Health England·Phase 4·NCT02526394·400 enrolled

Acellular Pertussis1 trial

Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

Active, not recruiting·BBioNet-Asia Co., Ltd.·Phase 3·NCT06798831·2,399 enrolled

Whooping Cough1 trial

Optimising the Timing of Whooping Cough Immunisation in MUMs

Unknown status·SSt George's, University of London·Phase 4·NCT03908164·354 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Pertussis containing vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pertussis containing vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pertussis containing vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — St George's, University of London company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: SSt George's, University of London

Pertussis containing vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Meningitis1 trial

Acellular Pertussis1 trial

Whooping Cough1 trial

References

Drug Info

Quick Facts

Related News